| |
| |
|
| Insider
Information: |
Ignelzi Troy A. |
| Relationship: |
|
| City: |
Plymouth |
| State: |
MI |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
30,487 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
30,487 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Scpharmaceuticals Inc. |
SCPH |
|
|
0 |
|
0 |
Premium* |
|
|
Karuna Therapeutics, Inc. |
KRTX |
|
2023-08-22 |
30,487 |
2020-03-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-01-18 |
4 |
AS |
$200.14 |
$40,028 |
D/D |
(200) |
21,837 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-02-21 |
4 |
AS |
$190.01 |
$1,140,060 |
D/D |
(6,000) |
30,487 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-05-23 |
4 |
AS |
$221.28 |
$2,010,662 |
D/D |
(9,000) |
30,487 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• • – |
2023-08-22 |
4 |
AS |
$173.64 |
$262,683 |
D/D |
(1,500) |
30,487 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-03-02 |
4 |
OE |
$9.20 |
$69,000 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-05-08 |
4 |
OE |
$9.20 |
$69,000 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-06-15 |
4 |
OE |
$9.20 |
$55,200 |
D/D |
6,000 |
4,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-06-16 |
4 |
OE |
$9.20 |
$18,400 |
D/D |
2,000 |
2,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-07-08 |
4 |
OE |
$9.20 |
$73,600 |
D/D |
8,000 |
8,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-08-25 |
4 |
OE |
$9.20 |
$46,000 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-09-08 |
4 |
OE |
$9.20 |
$18,400 |
D/D |
2,000 |
7,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-11-06 |
4 |
OE |
$9.20 |
$5,189 |
D/D |
564 |
5,564 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-11-09 |
4 |
OE |
$9.20 |
$85,726 |
D/D |
9,318 |
6,318 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-11-10 |
4 |
OE |
$9.20 |
$1,086 |
D/D |
118 |
5,118 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-12-29 |
4 |
OE |
$9.20 |
$73,600 |
D/D |
8,000 |
13,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-01-08 |
4 |
OE |
$9.20 |
$73,600 |
D/D |
8,000 |
21,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-02-16 |
4 |
OE |
$9.20 |
$92,000 |
D/D |
10,000 |
23,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-05-10 |
4 |
OE |
$9.20 |
$64,400 |
D/D |
7,000 |
20,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-05-12 |
4 |
OE |
$9.20 |
$1,840 |
D/D |
200 |
13,200 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-08-20 |
4 |
OE |
$9.20 |
$46,000 |
D/D |
5,000 |
18,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-09-08 |
4 |
OE |
$9.20 |
$69,920 |
D/D |
7,600 |
18,600 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-09-09 |
4 |
OE |
$9.20 |
$4,600 |
D/D |
500 |
18,500 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-09-10 |
4 |
OE |
$9.20 |
$17,480 |
D/D |
1,900 |
19,900 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-11-08 |
4 |
OE |
$9.20 |
$124,200 |
D/D |
13,500 |
31,500 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-12-21 |
4 |
OE |
$9.20 |
$64,124 |
D/D |
6,970 |
24,970 |
0 |
- |
|
65 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
